Nomura Sachiko, Suzuki Hidekazu, Masaoka Tatsuhiro, Kurabayashi Kumiko, Ishii Hiromasa, Kitajima Masaki, Nomoto Kikuo, Hibi Toshifumi
Center for Integrated Medical Research, Keio University School of Medicine, Tokyo, Japan.
Helicobacter. 2005 Feb;10(1):43-52. doi: 10.1111/j.1523-5378.2005.00290.x.
Helicobacter pylori is known to be a major pathogenic factor in the development of gastritis, peptic ulcer disease and gastric cancer. Recently, chicken egg yolk immunoglobulin Y (IgY) has been recognized as an inexpensive antibody source for passive immunization against gastrointestinal infections. The present study was designed to investigate the effect of anti-urease IgY on H. pylori infection in Mongolian gerbils.
H. pylori-infected Mongolian gerbils were administered a diet containing anti-urease IgY, with or without famotidine (F). After 10 weeks, bacterial culture and measurement of the gastric mucosal myeloperoxidase (MPO) activity were performed. In a second experiment, another group of gerbils was started on a diet containing F + IgY a week prior to H. pylori inoculation. After 9 weeks, these animals were examined.
In the H. pylori-infected gerbils, there were no significant differences in the level of H. pylori colonization among the different dietary and control groups. However, the MPO activity was significantly decreased in the H. pylori group administered the F + IgY diet compared with that in the H. pylori group administered the IgY, F, or control diet. Furthermore, in the gerbils administered the F + IgY diet prior to the bacterial inoculation, inhibition of H. pylori colonization and suppression of the elevated gastric mucosal MPO activity were observed.
Oral administration of urease-specific IgY not only inhibited H. pylori disease activity in H. pylori-infected gerbils, but also prevented H. pylori colonization in those not yet infected. These encouraging results may pave the way for a novel therapeutic and prophylactic approach in the management of H. pylori-associated gastroduodenal disease.
幽门螺杆菌是胃炎、消化性溃疡病和胃癌发生的主要致病因素。近来,鸡卵黄免疫球蛋白Y(IgY)已被公认为是一种用于被动免疫以预防胃肠道感染的廉价抗体来源。本研究旨在探讨抗脲酶IgY对蒙古沙鼠幽门螺杆菌感染的影响。
给感染幽门螺杆菌的蒙古沙鼠喂食含抗脲酶IgY的饲料,添加或不添加法莫替丁(F)。10周后,进行细菌培养并测定胃黏膜髓过氧化物酶(MPO)活性。在第二项实验中,另一组沙鼠在接种幽门螺杆菌前一周开始喂食含F + IgY的饲料。9周后,对这些动物进行检查。
在感染幽门螺杆菌的沙鼠中,不同饮食组和对照组之间幽门螺杆菌定植水平无显著差异。然而,与喂食IgY、F或对照饮食的幽门螺杆菌组相比,喂食F + IgY饮食的幽门螺杆菌组的MPO活性显著降低。此外,在细菌接种前喂食F + IgY饮食的沙鼠中,观察到幽门螺杆菌定植受到抑制,胃黏膜MPO活性升高受到抑制。
口服脲酶特异性IgY不仅能抑制感染幽门螺杆菌的沙鼠的幽门螺杆菌疾病活动,还能预防未感染沙鼠的幽门螺杆菌定植。这些令人鼓舞的结果可能为幽门螺杆菌相关性胃十二指肠疾病的新型治疗和预防方法铺平道路。